[JCY] QoQ Annualized Quarter Result on 31-Dec-2014 [#1]

Stock
[JCY] JCY INTERNATIONAL BERHAD
Announcement Date
13-Feb-2015
Admission Sponsor
-
Sponsor
-
Financial Year
30-Sep-2015
Quarter
31-Dec-2014 [#1]
Profit Trend
QoQ- 82.69%
YoY- 65.89%
Quarter Report
Latest QR
Upcoming QR
JCY's Result
JCY's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Revenue 1,942,312 1,968,558 1,993,330 1,951,472 1,867,170 1,873,018 1,904,268 1.32%
PBT 207,228 182,920 207,072 204,188 122,811 126,925 139,124 30.39%
Tax 2,272 -4,396 -4,394 -3,440 -12,926 -2,413 -2,414 -
NP 209,500 178,524 202,678 200,748 109,885 124,512 136,710 32.88%
-
NP to SH 209,500 178,524 202,678 200,748 109,885 124,512 136,710 32.88%
-
Tax Rate -1.10% 2.40% 2.12% 1.68% 10.53% 1.90% 1.74% -
Total Cost 1,732,812 1,790,034 1,790,652 1,750,724 1,757,285 1,748,506 1,767,558 -1.31%
-
Net Worth 1,285,123 1,223,350 1,208,757 1,162,834 1,122,021 1,116,750 1,119,237 9.64%
Dividend
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Div 137,560 101,742 101,542 81,274 86,356 60,902 40,566 125.54%
Div Payout % 65.66% 56.99% 50.10% 40.49% 78.59% 48.91% 29.67% -
Equity
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Net Worth 1,285,123 1,223,350 1,208,757 1,162,834 1,122,021 1,116,750 1,119,237 9.64%
NOSH 2,037,937 2,034,847 2,030,841 2,031,862 2,031,912 2,030,086 2,028,338 0.31%
Ratio Analysis
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
NP Margin 10.79% 9.07% 10.17% 10.29% 5.89% 6.65% 7.18% -
ROE 16.30% 14.59% 16.77% 17.26% 9.79% 11.15% 12.21% -
Per Share
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
RPS 95.31 96.74 98.15 96.04 91.89 92.26 93.88 1.01%
EPS 10.28 8.77 9.98 9.88 5.41 6.13 6.74 32.46%
DPS 6.75 5.00 5.00 4.00 4.25 3.00 2.00 124.83%
NAPS 0.6306 0.6012 0.5952 0.5723 0.5522 0.5501 0.5518 9.29%
Adjusted Per Share Value based on latest NOSH - 2,031,862
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
RPS 90.43 91.65 92.81 90.86 86.93 87.21 88.66 1.32%
EPS 9.75 8.31 9.44 9.35 5.12 5.80 6.37 32.77%
DPS 6.40 4.74 4.73 3.78 4.02 2.84 1.89 125.33%
NAPS 0.5983 0.5696 0.5628 0.5414 0.5224 0.5199 0.5211 9.63%
Price Multiplier on Financial Quarter End Date
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Date 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 -
Price 0.67 0.705 0.705 0.545 0.635 0.70 0.725 -
P/RPS 0.70 0.73 0.72 0.57 0.69 0.76 0.77 -6.15%
P/EPS 6.52 8.04 7.06 5.52 11.74 11.41 10.76 -28.37%
EY 15.34 12.44 14.16 18.13 8.52 8.76 9.30 39.56%
DY 10.07 7.09 7.09 7.34 6.69 4.29 2.76 136.81%
P/NAPS 1.06 1.17 1.18 0.95 1.15 1.27 1.31 -13.15%
Price Multiplier on Announcement Date
30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 31/03/14 CAGR
Date 23/11/15 19/08/15 20/05/15 13/02/15 26/11/14 21/08/14 19/05/14 -
Price 0.88 0.65 0.77 0.725 0.555 0.71 0.745 -
P/RPS 0.92 0.67 0.78 0.75 0.60 0.77 0.79 10.67%
P/EPS 8.56 7.41 7.72 7.34 10.26 11.58 11.05 -15.63%
EY 11.68 13.50 12.96 13.63 9.74 8.64 9.05 18.52%
DY 7.67 7.69 6.49 5.52 7.66 4.23 2.68 101.44%
P/NAPS 1.40 1.08 1.29 1.27 1.01 1.29 1.35 2.45%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment